Volume: 43 Issue: 3
Year: 2023, Page: 882-885, Doi: https://doi.org/10.51248/.v43i3.2820
Introduction and Aim: Chronic kidney disease also referred as chronic renal disease is a condition in which there is a gradual loss of kidney function. End-stage renal failure (ESRD) is the final stage of the disease in which the kidneys cease to function, and the patient continues to depend on long-term dialysis. In this study we aimed to analyze the relationship between parathyroid hormone (PTH), electrolyte disturbances and vitamin D3 in ESRD patients and compare it to healthy individuals.
Materials and Methods: 100 outpatients (ages 30-70 years) from Al-Diwaniyah General Hospital and 49 healthy participants (ages 35-65 years) were investigated between July and October 2022.
Results: A significant increase in PTH concentrations was observed in the ESRD group 275.16 ± 224.03 pg/ml) when compared to the healthy group (44.42 ± 19.26 pg/ml). Similarly, phosphate concentrations differed significantly between ESRD patients and the healthy group (1.52 ± 0.53 vs. 1.04 ± 0.15 mmol/L, respectively).
A non-significant positive correlation was noticed between PTH and phosphate levels (p value = 0.068; r = 0.253). There was a significant (p-value 0.001) decrease in calcium levels between patients and healthy samples (2.06 ± 0.28 mmol/L vs. 2.36 ± 0.11, respectively), and a negative correlation (r = -0.536) between PTH and calcium levels. The vitamin D3 values showed no significant differences (p > 0.01), between ESRD patients and healthy subjects.
Conclusion: A positive correlation existed between serum PTH and phosphate levels in patients with ESRD. Hence these parameters could be monitored on a regular basis to ensure appropriate dietary and medical treatments
Keywords: Electrolytes; parathyroid hormones; renal failure; vitamin D3.
1. Yeo, F.E., Villines, T.C., Bucci, J.R., Taylor, A.J., Abbott, K.C. Cardiovascular risk in stage 4 and 5 nephropathies. Adv Chronic Kidney Dis. 2004; 11: 116-133.
2. Lokapur, V., Jayakar, V., Divakar, M.S., Chalannavar, R.K., Lasrado, L., Shantaram, M. ZnO nanoparticles with spectroscopically controlled morphology, bioinspired from Holigarna grahamii (Wight) Kurz and delving its antioxidant and anticancer potential on A498 cell line. Materials Today Communications. 2022 Jun 1;31:103338.
3. Zhou, X., Guo, Y., Luo, Y. The optimal range of serum intact parathyroid hormone for a lower mortality risk in incident hemodialysis patients. Renal Failure. 2021; 43(1):599-605.
4. Mafra, D., Lobo, J., Farage, N., Stockler-Pinto, M., Leal, V., Calixto, A., et al., The Relationship between Apelin and Parathyroid Hormone in Hemodialysis Patients. Renal Failure. 2012; 34(8):970-973.
5. Fang, L., Tang, B., Hou, D., Meng, M., Xiong, M., Yang, J. The effect of parathyroid hormone on serum magnesium levels is the neglected relationship in hemodialysis patients with
secondary hyperparathyroidism. Renal Failure. 2015; 38(1):50-56.
6. Chen, L., He, J., Chen, Y., Ling, Y., Lin, C., Guan, T. Intensified treatment of hyperphosphatemia associated with a reduction in parathyroid hormone in patients on maintenance hemodialysis. Renal Failure .2018; 40(1):15-21.
7. Elsurer, R., Afsa, B., Mercanoglu, E. Bone Pain Assessment and Relationship with Parathyroid Hormone and Health-Related Quality of Life in Hemodialysis. Renal Failure. 2013; 35(5):667-672.
8. Duan, S., Chen, X., Liu, Y., Guo, W., Liu, W. Endoplasmic reticulum stress mediates parathyroid hormone-induced apoptosis in vascular smooth muscle cells. Renal Failure .2022; 44(1):126-136.
9. Liu, Y., Wu, Y., Diao, Z., Guo, W., Liu, W. Resveratrol inhibits parathyroid hormone-induced apoptosis in human aortic smooth muscle cells by upregulating sirtuin 1. Renal Failure. 2019; 41(1):401-407.
10. Kovacs, C. Overview paper: Complementary and overlapping role of Parathyroid Hormone (PTH) and PTH-related Protein (PTHrP) in regulating fetal mineral homeostasis. Bone. 2011; 48: S62.
11. Almaden, Y., Hernandez, A., Torregrosa, V., Canalejo, A., Sabate, L., Fernandez-Cruz, L., et al., High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol. 1998; 9: 1845-1852.
12. Kurokawa, K. The kidney and calcium homeostasis. Kidney Int Suppl. 1994; 44: S97-105.
13. Yamamoto, M., Igarashi, T., Muramatsu, M., Fukagawa, M., Motokura, T., Ogata, E. Hypocalcemia increases, and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat. J Clin Invest. 1989; 83:1053-1056.
14. Hamann, K.L., Lane, N.E .Parathyroid hormone update. Rheum Dis Clin North Am. 2006; 32: 703-719.
15. Elayalwar, S., Lakshmipathi, J. A study to assess the association between serum neopterin levels and various biochemicals, clinical, and echocardiographic variables. J Evol. Med & Den. Sci. 2016; 5(57):3890-3893.
16. Jean, G., Lataillade, D., Genet, L., Legrand, E., Kuentz, F., Moreau-Gaudry, X., et al., Association between Very Low PTH Levels and Poor Survival Rates in Haemodialysis Patients: Results from the French ARNOS Cohort. Nephron Clinical Practice. 2010; 118(2): c211-c216.
17. Teng, M., Wolf, M., Ofsthun, M.N., Lazarus, J.M., Hernán, M.A., Camargo, C.A., et al., Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol. 2005; 16(4): 1115-1125.
18. Patel, S., Hyer, S., Barron, J. Glomerular filtration rate is as a major determinant of the relationship between 25-hydroxy- vitamin D and parathyroid hormone. Calcif Tissue Int. 2007; 80:221-226.
19. Llach, F., Velasquez, F. Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects. Am J Kidney Dis. 2001; 38(5 Suppl 5): S20-S33.
20. Garcia, V., Schuch, N., Cicca, M., Ferreira, S., Martini, L. PP115-Mon association between vitamin D, intact PTH and blood pressure: Cut point of PTH for hypertension. Clinical Nutrition Supplements. 2011; 6(1):157-158
21. Andress, D.L. Vitamin D treatment in chronic kidney disease. Semin Dial. 2005. 18: 315-321.
22. Gonzalez, E.A., Sachdeva, A., Oliver, D.A., Martin, K.J. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol. 2004; 24: 503-510.
Aseel Ibrahim Suhael, Lana Nazar Abdul-Razzaq, Majid M. Mahmood. Imbalances in parathyroid hormones and few electrolytes in patients with renal failure. Biomedicine: 2023; 43(3): 882-885